Enhabit, Inc. (NYSE:EHAB) is AREX Capital Management LP’s Largest Position

AREX Capital Management LP lifted its position in shares of Enhabit, Inc. (NYSE:EHAB) by 2.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,490,795 shares of the company’s stock after buying an additional 48,874 shares during the quarter. Enhabit makes up 27.7% of AREX Capital Management LP’s holdings, making the stock its largest holding. AREX Capital Management LP’s holdings in Enhabit were worth $19,453,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. 8 Knots Management LLC grew its holdings in Enhabit by 16.4% during the 4th quarter. 8 Knots Management LLC now owns 4,430,898 shares of the company’s stock valued at $34,605,000 after buying an additional 623,602 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Enhabit by 12.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,953,941 shares of the company’s stock valued at $15,260,000 after acquiring an additional 213,774 shares during the last quarter. Paradice Investment Management LLC lifted its stake in Enhabit by 12.8% in the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company’s stock worth $13,903,000 after purchasing an additional 201,997 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Enhabit by 37.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company’s stock valued at $2,411,000 after purchasing an additional 83,707 shares during the last quarter. Finally, ExodusPoint Capital Management LP purchased a new position in shares of Enhabit during the fourth quarter valued at about $593,000.

Enhabit Price Performance

Enhabit stock opened at $8.02 on Friday. Enhabit, Inc. has a 52-week low of $6.85 and a 52-week high of $10.70. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm’s fifty day moving average is $8.28 and its 200 day moving average is $8.02. The company has a market cap of $404.85 million, a price-to-earnings ratio of -3.46 and a beta of 1.60.

Analysts Set New Price Targets

Separately, Jefferies Financial Group reiterated a “buy” rating on shares of Enhabit in a research report on Thursday, March 6th.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.